UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy

Supportive care in cancer, 2021-09, Vol.29 (9), p.5417-5423

2021

Volltextzugriff (PDF)

Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic

Supportive care in cancer, 2021-07, Vol.29 (7), p.4159-4164

2021

Volltextzugriff (PDF)

Frontline Management of Advanced Epithelial Ovarian Cancer: A Comprehensive Statement by the Africa Middle East Cancer Inter-group [AMCI]

Current women's health reviews, 2024-01, Vol.20 (1)

2024

Volltextzugriff (PDF)

Bilateral Testicular Plasmacytoma Preceding Multiple Myeloma with Extramedullary Renal Involvement: A Case Report

Plasmatology, 2024-08, Vol.18

2024

Volltextzugriff (PDF)

Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards

Journal of oncology pharmacy practice, 2022-12, Vol.28 (8), p.1807-1811

2022

Volltextzugriff (PDF)

Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab

Biomolecules & Biomedicine, 2024-08, Vol.24 (4), p.998-1003

2024

Volltextzugriff (PDF)

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

The New England journal of medicine, 2021-11, Vol.385 (20), p.1856-1867

2021

Volltextzugriff (PDF)

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

The New England journal of medicine, 2022-02, Vol.386 (5), p.437-448

2022

Volltextzugriff (PDF)

Biochemical Response Evaluation on Lymphomas: Proposing a Scoring System

Uluslararası hematologi-onkoloji dergisi, 2023-01, Vol.33 (3), p.170-178

Erdat, Efe Cem

2023

Volltextzugriff (PDF)

Association between common risk factors and molecular subtypes in breast cancer patients

Breast (Edinburgh), 2013-06, Vol.22 (3), p.344-350

2013

Volltextzugriff (PDF)

Lycopene sensitizes the cervical cancer cells to cisplatin via targeting nuclear factor- kappa B (NF-κB) pathway

TURKISH JOURNAL OF MEDICAL SCIENCES, 2021-02, Vol.51 (1), p.368-374

2021

Volltextzugriff (PDF)

The efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: A multicenter study by the Turkish Oncology Group (TOG)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e17534-e17534

2024

Volltextzugriff (PDF)

Immunogenicity of two doses of inactive COVID‐19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy

International journal of cancer, 2023-02, Vol.152 (4), p.679-685

2023

Volltextzugriff (PDF)

Is microsatellite instability a negative prognostic factor in early stage endometrial cancer patients?

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e17107-e17107

2019

Volltextzugriff (PDF)

Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia

Current oncology (Toronto), 2023-11, Vol.30 (11), p.9689-9700

2023

Volltextzugriff (PDF)

Safety and survival in adult women with platinum sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17509-e17509

2023

Volltextzugriff (PDF)

Should Protocols Specific to Histologic Subtypes Be Applied in the Follow-Up of NSCLC?

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.e77-e77

2021

Volltextzugriff (PDF)

Defining the Optimal Regimen for Stage III Colon Cancer: Concerns with Study Design

Clinical colorectal cancer, 2020-09, Vol.19 (3), p.e71-e72

2020

Volltextzugriff (PDF)

Perspectives, fears and expectations of patients with gynaecological cancers during the COVID‐19 pandemic: A Pan‐European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)

Cancer medicine (Malden, MA), 2021-01, Vol.10 (1), p.208-219

2021

Volltextzugriff (PDF)

KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer

Biomarkers in medicine, 2024-06, Vol.18 (10-12), p.511-511

2024

Volltextzugriff (PDF)

Cessation of Rectal Screening for Vancomycin-Resistant Enterococci: Experience from a Tertiary Care Hospital from Türkiye

Healthcare (Basel), 2023-09, Vol.11 (19), p.2641

2023

Volltextzugriff (PDF)

Newly diagnosed cancer and the COVID-19 pandemic: tumour stage migration and higher early mortality

BMJ supportive & palliative care, 2021-10, Vol.14 (e1), p.e456-e461

2021

Volltextzugriff (PDF)

Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer

Asia-Pacific journal of clinical oncology, 2022-02, Vol.18 (1), p.84-92

2022

Volltextzugriff (PDF)

Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment

Anti-cancer drugs, 2022-01, Vol.33 (1), p.e477-e485

2022

Volltextzugriff (PDF)

Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer

Future oncology (London, England), 2024-02, Vol.20 (4), p.207-214

2024

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy

Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic

Frontline Management of Advanced Epithelial Ovarian Cancer: A Comprehensive Statement by the Africa Middle East Cancer Inter-group [AMCI]

Bilateral Testicular Plasmacytoma Preceding Multiple Myeloma with Extramedullary Renal Involvement: A Case Report

Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards

Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

Biochemical Response Evaluation on Lymphomas: Proposing a Scoring System

Association between common risk factors and molecular subtypes in breast cancer patients

Lycopene sensitizes the cervical cancer cells to cisplatin via targeting nuclear factor- kappa B (NF-κB) pathway

The efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: A multicenter study by the Turkish Oncology Group (TOG)

Immunogenicity of two doses of inactive COVID‐19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy

Is microsatellite instability a negative prognostic factor in early stage endometrial cancer patients?

Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia

Safety and survival in adult women with platinum sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

Should Protocols Specific to Histologic Subtypes Be Applied in the Follow-Up of NSCLC?

Defining the Optimal Regimen for Stage III Colon Cancer: Concerns with Study Design

Perspectives, fears and expectations of patients with gynaecological cancers during the COVID‐19 pandemic: A Pan‐European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)

KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer

Cessation of Rectal Screening for Vancomycin-Resistant Enterococci: Experience from a Tertiary Care Hospital from Türkiye

Newly diagnosed cancer and the COVID-19 pandemic: tumour stage migration and higher early mortality

Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer

Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment

Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer

Suchergebnisse filtern